5:07 PM
 | 
Apr 12, 2012
 |  BC Extra  |  Company News

Bayer seeks expansion of EU label for Xarelto

Bayer AG (Xetra:BAYN) submitted an MAA to EMA for oral Xarelto rivaroxaban to treat pulmonary embolism (PE) and to prevent recurrent deep...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >